NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
NEUTRA CORP.
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Neutra statistics
Financials through Jan 31, 2023, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | Neutra | Industry median |
|---|---|---|
| Market Cap | $291.79K | $197.05M |
| Enterprise Value | $343.98K | $106.56M |
| PS Ratio | 4.29 | 3.93 |
Enterprise value
| Measure | Neutra | Industry median |
|---|---|---|
| EV / Sales | 5.06 | 2.69 |
Income (trailing twelve months)
| Measure | Neutra | Industry median |
|---|---|---|
| Revenue | $68.00K | $57.94M |
| Gross Profit | $35.31K | $90.47M |
| Operating Income | -$297.68K | -$21.44M |
| Pretax Income | -$557.89K | -$14.45M |
| Net Income | -$561.42K | -$22.46M |
| EBITDA | -$218.77K | -$16.91M |
Margins
| Measure | Neutra | Industry median |
|---|---|---|
| Gross Margin | 51.9% | 52.3% |
| Operating Margin | -437.8% | -44.5% |
| Pretax Margin | -820.5% | -13.0% |
| Profit Margin | -825.7% | -39.2% |
| EBITDA Margin | -321.7% | -31.3% |
Returns
| Measure | Neutra | Industry median |
|---|---|---|
| Return on Assets (ROA) | -544.8% | -41.0% |
Growth
| Measure | Neutra | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -26.1% | 6.01% |
| Revenue Growth (3Y CAGR) | 119.9% | 2.25% |
Balance sheet
| Measure | Neutra | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.97K | $62.42M |
| Total Debt | $54.16K | $120.13M |
| Net Cash (Debt) | -$52.19K | $15.68M |
| Net Cash Per Share | -$0.00 | $0.65 |
| Equity (Book Value) | -$773.82K | $48.79M |
| Book Value Per Share | -$0.00 | $1.36 |
| Tangible Book Value | -$773.82K | $23.06M |
| Working Capital | -$733.82K | $75.77M |
Financial position
| Measure | Neutra | Industry median |
|---|---|---|
| Current Ratio | 0.03 | 3.30 |
| Quick Ratio | 0.00 | 2.39 |
| Interest Coverage | -4.80 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Neutra | Industry median |
|---|---|---|
| Operating Cash Flow | -$153.24K | -$12.35M |
Efficiency
| Measure | Neutra | Industry median |
|---|---|---|
| Asset Turnover | 0.66 | 0.38 |
| Inventory Turnover | 1.37 | 2.67 |
| Revenue Per Employee | $4.53K | $398.96K |
| Profits Per Employee | -$37.43K | -$732.08K |
| Employee Count | 15 | 73 |
Dividends and yields
| Measure | Neutra | Industry median |
|---|---|---|
| Earnings Yield | -192.4% | -21.2% |
Shares
| Measure | Neutra | Industry median |
|---|---|---|
| Shares Outstanding | 2,917,900,000 | 59,128,900 |
| Float | 2,917,900,000 | 48,744,500 |
| Shares Held by Insiders | 0.00% | 11.8% |
Taxes
| Measure | Neutra | Industry median |
|---|---|---|
| Income Tax | $3.52K | $91.50K |
Scores
| Measure | Neutra | Industry median |
|---|---|---|
| Altman Z-Score | -237.07 | 0.10 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Neutra's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.